Related Experiment Video
Updated: May 25, 2026

Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation
Published on: November 7, 2020
Liver transplantation for Wilson disease
Andreea M Catana1, Valentina Medici
1Andreea M Catana, Valentina Medici, Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of California, Davis, Sacramento, CA 95817, United States.
Liver transplantation (LT) is crucial for Wilson disease (WD) patients with acute liver failure or advanced cirrhosis. While controversial in neuropsychiatric cases, LT offers excellent survival, with future therapies like gene therapy under investigation.
Area of Science:
- Hepatology
- Transplant Surgery
- Medical Genetics
Background:
- Wilson disease (WD) is a genetic disorder of copper metabolism leading to toxic copper accumulation in organs.
- Liver transplantation (LT) is a life-saving intervention for end-stage liver disease and acute liver failure (ALF) in WD.
- Current management involves copper-chelating agents, but LT remains essential for refractory or advanced cases.
Purpose of the Study:
- To review the current indications and controversies surrounding liver transplantation (LT) for Wilson disease (WD).
- To focus on LT in WD patients with neuropsychiatric involvement and acute liver failure (ALF).
- To discuss diagnostic approaches for Wilsonian ALF and future therapeutic options.
Main Methods:
- Literature review of current status, indications, and controversies of liver transplantation for Wilson disease.
- Analysis of diagnostic criteria for acute liver failure in Wilson disease.
- Evaluation of outcomes for deceased donor and living related liver transplantation in WD.
- Review of emerging therapeutic strategies such as hepatocyte transplantation and gene therapy.
Main Results:
- LT is the primary treatment for Wilsonian ALF and for chronic liver disease progressing to cirrhosis unresponsive to medical therapy.
- Early identification of Wilsonian ALF is critical, with 100% mortality without emergency LT.
- Simple biochemical tests show promise for diagnosing acute WD-related ALF.
- LT provides excellent 1- and 5-year survival rates, correcting copper metabolism and WD complications.
- Living related LT is a viable alternative with excellent outcomes and no disease recurrence.
Conclusions:
- Liver transplantation is a definitive treatment for Wilson disease with acute liver failure or advanced cirrhosis.
- Indications for LT in WD patients with progressive neurological disease remain debated.
- Hepatocyte transplantation and gene therapy represent promising future alternatives requiring further human studies.
More Related Videos
Related Concept Videos
Kidney Transplant I: Introduction
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...

